Search Results

Search here to find what you are looking for. If you are searching for a Teva product, you may want to try searching in one of our product catalogues or feel free to contact us for assistance.

Showing 10 from 23 results

I have had the pleasure of collaborating with Christine for many years and wish her the best as she moves on to new experiences.

Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, join a growing list of provinces providing public drug plan reimbursement for Teva Canada’s AJOVY® (fremanezumab), for the preventive treatment of migraine in adults

Public formulary and program coverage makes AJOVY® accessible to more migraine patients across Canada

Teva Canada Charts a New Prescription for Care - New initiatives planned to spark dialogue on future healthcare delivery

April 5, 2022 – National Caregiver Day in Canada

New public drug plan reimbursement for AJOVY®

Teva Canada Welcomes Public Drug Plan Reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the Non-Insured Health Benefits Program for patients prescribed AJOVY® (fremanezumab) for the Preventive Treatment of Migraine in Adults

Important Information – Voluntary Nationwide Recall

Novo-Gesic Forte® 500 mg (Acetaminophen) Tablets (DIN 00482323)

Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions

Life Effects™ website features real-life stories from patients and caregivers about the reality of living with one or more chronic conditions

Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget

Teva Canada Announces New Autoinjector for AJOVY®for the Preventive Treatment of Migraine in Adults

Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma

Important safety information on prescription cough and cold products containing opioids and the risk of opioid ase disorder in children and adolescents